Abstract
<h3>Purpose</h3> Patients with hypertrophic obstructive cardiomyopathy (HOCM) often have concomitant pulmonary hypertension (PH). We hypothesize that concomitant PH is associated with increased risk for short-term adverse outcomes after septal myectomy. <h3>Methods</h3> We retrospectively evaluated 758 patients who underwent septal myectomy for treatment of HOCM between 2010 and 2020 at our institution. There were 396 total patients who had pre-op right heart catheterization (RHC). After exclusion of patients without complete RHC data, there were 281 patients included in the final analysis. Adverse events (AE) were defined by a composite endpoint which included post-operative stroke, TIA, MI, cardiac arrest, prolonged ventilation, reintubation, pneumonia, multi-organ failure, and mortality. Comparison was made between patients with and without AE. Categorical variables were compared with chi-square or Fisher's exact test where appropriate. Continuous variables were compared with one-way ANOVA. Significance was defined as p<0.05. <h3>Results</h3> The overall incidence of AE in the study population was low (n=17, 6%). Prolonged ventilation was the most common AE (n=9, 3.2%). Patients with AE were older in age (64 vs 57, p=.015) and were more likely to have chronic lung disease (OR 4.42, 95% CI 1.5-12.8; p=.003). On pre-op RHC, patients with AE had significantly greater pulmonary artery (PA) systolic pressure (47 vs 38, p=.010), mean PA pressure (32 vs 26, p=.017), PA pulsatility index (5.9 vs 3.8, p=.004), PA pulse pressure (28 vs 22, p=.009), transpulmonary gradient (13 vs 10, p=.02), and pulmonary vascular resistance (3.4 vs 2.0, p <.001). <h3>Conclusion</h3> Increased severity of concomitant PH in patients with HOCM undergoing septal myectomy surgery is associated with increased risk for short-term adverse outcomes. Preoperative pulmonary artery pressure is of prognostic predictive value. Screening for and treating PH before septal myectomy may reduce the risk of complications.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.